Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Obstetrics and Gynecology
Volume 2016, Article ID 3621802, 4 pages
http://dx.doi.org/10.1155/2016/3621802
Case Report

A Case of a Gastrointestinal Stromal Tumor Diagnosed at the Postpartum Period

1Dokuz Eylul University School of Medicine, Department of Obstetrics and Gynecology, Izmir, Turkey
2Dokuz Eylul University School of Medicine, Department of Surgery, Izmir, Turkey
3Dokuz Eylul University School of Medicine, Department of Medical Oncology, Izmir, Turkey
4Dokuz Eylul University School of Medicine, Department of Pathology, Izmir, Turkey
5Dokuz Eylul University School of Medicine, Department of Radiodiagnostics, Izmir, Turkey

Received 12 August 2016; Revised 30 October 2016; Accepted 31 October 2016

Academic Editor: Yoshio Yoshida

Copyright © 2016 Sefa Kurt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Pereg, G. Koren, and M. Lishner, “Cancer in pregnancy: gaps, challenges and solutions,” Cancer Treatment Reviews, vol. 34, no. 4, pp. 302–312, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Salani, C. C. Billingsley, and S. M. Crafton, “Cancer and pregnancy: an overview for obstetricians and gynecologists,” American Journal of Obstetrics and Gynecology, vol. 211, no. 1, pp. 7–14, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. L.-G. Kindblom, H. E. Remotti, F. Aldenborg, and J. M. Meis-Kindblom, “Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal,” The American Journal of Pathology, vol. 152, no. 5, pp. 1259–1269, 1998. View at Google Scholar · View at Scopus
  4. K. Sircar, B. R. Hewlett, J. D. Huizinga, K. Chorneyko, I. Berezin, and R. H. Riddell, “Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors,” The American Journal of Surgical Pathology, vol. 23, no. 4, pp. 377–389, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Sakurai, T. Fukasawa, J.-M. Chong, A. Tanaka, and M. Fukayama, “Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal,” The American Journal of Pathology, vol. 154, no. 1, pp. 23–28, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. T. L. Robinson, K. Sircar, B. R. Hewlett, K. Chorneyko, R. H. Riddell, and J. D. Huizinga, “Gastrointestinal stromal tumors may originate from a subset of CD34-positive interstitial cells of Cajal,” The American Journal of Pathology, vol. 156, no. 4, pp. 1157–1163, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Miettinen and J. Lasota, “Histopathology of gastrointestinal stromal tumor,” Journal of Surgical Oncology, vol. 104, no. 8, pp. 865–873, 2011. View at Publisher · View at Google Scholar
  8. H. Stensheim, B. Møller, T. Van Dijk, and S. D. Fosså, “Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study,” Journal of Clinical Oncology, vol. 27, no. 1, pp. 45–51, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. A. L. V. Johansson, T. M.-L. Andersson, C.-C. Hsieh, S. Cnattingius, and M. Lambe, “Increased mortality in women with breast cancer detected during pregnancy and different periods postpartum,” Cancer Epidemiology Biomarkers and Prevention, vol. 20, no. 9, pp. 1865–1872, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Ives, C. Saunders, M. Bulsara, and J. Semmens, “Pregnancy after breast cancer: population based study,” British Medical Journal, vol. 334, no. 7586, pp. 194–196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. E. Voulgaris, G. Pentheroudakis, and N. Pavlidis, “Cancer and pregnancy: a comprehensive review,” Surgical Oncology, vol. 20, no. 4, pp. e175–e185, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. O. Buyukasik, A. O. Hasdemir, A. Dirican, and C. Çol, “Gastrointestinal stromal tümörler,” Inönü Üniversitesi Tip Fakültesi Dergisi, vol. 16, pp. 227–232, 2009. View at Google Scholar
  13. M. S. Canda, “Gastrointestinal stromal tumors, interstitial cells of cajal and their nomenclature,” Journal of Gastrointestinal & Digestive System, vol. 4, article 432, 2014. View at Publisher · View at Google Scholar
  14. P. Bucher, P. Villiger, J. F. Eggberg, L. H. Buhler, and P. Morel, “Management of gastrointestinal stromal tumors: from diagnosis to treatment,” Swiss Medical Weekly, vol. 134, pp. 145–153, 2004. View at Google Scholar
  15. Z. M. Bamboat and R. P. DeMatteo, “Updates on the management of gastrointestinal stromal tumors,” Surgical Oncology Clinics of North America, vol. 21, no. 2, pp. 301–316, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. Tan, J. C. Garcia-Buitrago, J. C. Trent, and A. E. Rosenberg, “The immune system and gastrointestinal stromal tumor: a wealth of opportunities,” Current Opinion in Oncology, vol. 27, no. 4, pp. 338–342, 2015. View at Publisher · View at Google Scholar
  17. G. D. Demetri, M. von Mehren, C. R. Antonescu et al., “NCCN task force report: update on the management of patients with gastrointestinal stromal tumors,” JNCCN: Journal of the National Comprehensive Cancer Network, vol. 8, no. 2, pp. S1–S40, 2010. View at Google Scholar · View at Scopus
  18. J. D. Murphy, G. L. Ma, J. M. Baumgartner et al., “Increased risk of additional cancers among patients with gastrointestinal stromal tumors: a population-based study,” Cancer, vol. 121, no. 17, pp. 2960–2967, 2015. View at Publisher · View at Google Scholar · View at Scopus